Marijuana Rescheduling Hearing: Final Briefs Due August 17

Monday, August 17 is the next real date in the federal marijuana rescheduling hearing, and it is a paperwork deadline rather than a verdict. Chief Administrative Law Judge Derek Julius set August 17 as the cutoff for designated parties to file optional post-hearing briefs of up to 50 pages, and the same date for proposed corrections to the hearing transcripts. After that, Julius writes a recommendation. There is no deadline for it. Anyone promising you cannabis will be Schedule III by Halloween is guessing.

marijuana rescheduling hearing

In this article

What the marijuana rescheduling hearing actually decided

Nothing yet. The hearing opened June 29 and closed July 15 after more than two weeks of testimony on the proposal to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. It followed a notice of hearing issued by Acting Attorney General Todd Blanche in April as part of an expedited process.

Julius made clear that briefing is voluntary. In his order he wrote: “This is a nonmandatory submission; therefore, a Designated Party will not be penalized for not filing a post-hearing brief, and the absence of a submission implies that no submission was intended.”

Transcript corrections are narrow — misspellings, remarks attributed to the wrong speaker. They cannot be used to revise testimony or to clean up a witness who misspoke on the record.

Look at who was in the room

This is the detail that gets skipped. Aside from DEA itself, the designated parties consisted exclusively of organizations, physicians and state governments opposing broader rescheduling: the National Drug & Alcohol Screening Association, Smart Approaches to Marijuana, the Tennessee Bureau of Investigation, DUID Victim Voices, physicians Kenneth Finn and Phillip Drum, and the states of Nebraska, Idaho and Indiana.

Federal officials testified in support of Schedule III. But the adversarial half of the record — the part built for appeal — was constructed entirely by people who want the proposal dead. That shapes what a reviewing court sees later.

The timeline nobody wants to hear

Here is the actual sequence. Julius reviews briefs and transcripts, then drafts a recommended decision. It is not binding. Parties then get 20 days after receiving his report to file exceptions challenging his findings of fact or conclusions of law. The record goes to the DEA Administrator, who makes the agency’s final call. Julius said at the close of the hearing that he could not provide a timeline for either his recommendation or DEA’s final decision.

Translate that: recommendation, exceptions, administrator review, then near-certain litigation. Late 2026 is optimistic for step one.

Meanwhile, medical cannabis already moved

Do not conflate the two tracks. On a separate and already-completed track, DOJ issued a final order in April 2026 moving FDA-approved marijuana drug products and marijuana subject to a state medical marijuana license from Schedule I to Schedule III. That is done. It is also being challenged in the D.C. Circuit, in petitions including Smart Approaches to Marijuana, Inc. v. Department of Justice, filed May 4, 2026.

So the map right now: state-licensed medical cannabis is Schedule III and under attack in court. Adult-use is Schedule I and waiting on an ALJ. That split is why Illinois dispensaries are suddenly interested in medical licenses — the schedule follows the license, and the license is the only lever an operator actually controls.

What operators should do with this

Nothing dramatic on Monday. But two things are worth doing now. Watch whether any designated party files a brief that builds a strong procedural record — that is the seed of the eventual appeal. And stop treating “Schedule III” as one event with one date. It arrived in April for part of the industry and has not arrived at all for the rest.

Watch the full episode

Prefer to watch on YouTube? The Future of Dispensaries in Schedule III.

Original sources

This article is general information, not legal advice.

Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.
Picture of Thomas Howard

Thomas Howard

a seasoned cannabis business attorney, entrepreneur, and advocate with over a decade of hands-on experience navigating complex cannabis regulations across the United States. As the founder of Cannabis Industry Lawyer and co-host of Cannabis Legalization News, Tom has helped clients win cannabis licenses in multiple states, advised startups from seed to sale, and litigated key industry cases involving constitutional challenges and regulatory disputes. He’s personally built and launched cannabis businesses, giving him a rare combination of legal expertise and real-world operational insight. Tom has studied thousands of pages of cannabis laws and rules, testified on legalization issues, and regularly appears in media to break down developments in plain English. His mission: to fight outdated prohibition, empower entrepreneurs, and provide trustworthy, actionable information to anyone building a future in the legal cannabis industry.

Get Our Email

Sign up for our newsletter to receive product updates, exclusive discounts, and VIP webinar access

Related Posts

Subscribe to our Newsletter